Max Healthcare Institute (MAXHEALTH) — Financial Results

Max Healthcare reported Q1 FY26 gross revenue of ₹2,574 crores with 27% YoY growth and operating EBITDA of ₹613 crores (23% YoY growth), marking the 19th consecutive quarter of YoY expansion. Profit after tax reached ₹345 crores (17% YoY growth). The company is executing aggressive expansion with ~1,000 brownfield and 500 greenfield beds planned for FY26. Key growth drivers include Lucknow's exceptional 97% YoY revenue growth, Dwarka's 24% QoQ expansion, and oncology revenue at 25-26% of hospital revenues. Management expects net debt to increase ₹400-500 crores by FY26-end while maintaining leverage below 1.0x.

📄 View Original Announcement (PDF)

📊 Stock Analysis — MAXHEALTH ✨ Ask AI About This

About Max Healthcare Institute Limited (MAXHEALTH)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹1,02,200.33 Cr P/E: 101.2

View full MAXHEALTH stock details →

📡 Get AI alerts when MAXHEALTH files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MAXHEALTH — Free

💡 Ask AI about this filing

"How does this financial results affect Max Healthcare Institute Limited's outlook?" "What did Max Healthcare Institute Limited announce on 21 August 2025?" "Is this positive or negative for MAXHEALTH?"

Ask AI Free →

📊 More MAXHEALTH filings

See all MAXHEALTH filings →

🔥 Also filed on 21 August 2025

VEDL Vedanta Limited Corporate Action IOC Indian Oil Corporation Limited Corporate Action WIPRO Wipro Limited Corporate Action CHOLAFIN Cholamandalam Investment and Finance Company Limited Corporate Action VEDL Vedanta Limited Corporate Action LUPIN Lupin Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MAXHEALTH files new disclosures

Track MAXHEALTH filings, board meetings, and corporate actions. Free email alerts at 5 PM.